| Dr Pearl Carrillo, DO | |
|
2305 S Highway 65 Bldg A, Marshall, MO 65340-3702 | |
| (660) 886-7800 | |
| (660) 831-3306 |
| Full Name | Dr Pearl Carrillo |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 2305 S Highway 65 Bldg A, Marshall, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487602991 | NPI | - | NPPES |
| 205472509 | Medicaid | MO | |
| 38337016 | Other | MO | BLUE CROSS BLUE SHIELD OF KC |
| 795915 | Other | MO | HEALTHLINK PIN |
| H43884 | Other | MO | MERCY HEALTH PLANS PIN |
| 7713239 | Other | MO | AETNA PIN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2007001548 (Missouri) | Secondary |
| 207Q00000X | Family Medicine | 2007001548 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fitzgibbon Memorial Hospital | Marshall, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| John Fitzgibbon Memorial Hospital Inc | 2567351570 | 86 |
News Archive
In a joint position statement, Obesity Care Continuum (OCC) partners agree with the premise behind a recent European Court of Justice ruling supporting disability protections for obesity under certain circumstances and call for these protections to be enacted in the United States.
The American Association of Neuromuscular & Electrodiagnostic Medicine is now accepting abstracts for its 2020 annual meeting in Orlando, Florida.
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.
A new guideline published in this week's BMJ will help to tackle one of the leading causes of illness and death during pregnancy.
› Verified 3 days ago
| Entity Name | John Fitzgibbon Memorial Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730182478 PECOS PAC ID: 2567351570 Enrollment ID: O20040315000980 |
News Archive
In a joint position statement, Obesity Care Continuum (OCC) partners agree with the premise behind a recent European Court of Justice ruling supporting disability protections for obesity under certain circumstances and call for these protections to be enacted in the United States.
The American Association of Neuromuscular & Electrodiagnostic Medicine is now accepting abstracts for its 2020 annual meeting in Orlando, Florida.
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.
A new guideline published in this week's BMJ will help to tackle one of the leading causes of illness and death during pregnancy.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pearl Carrillo, DO 2305 South 65 Highway, P O Box 158, Marshall, MO 65340-3702 Ph: (660) 886-7431 | Dr Pearl Carrillo, DO 2305 S Highway 65 Bldg A, Marshall, MO 65340-3702 Ph: (660) 886-7800 |
News Archive
In a joint position statement, Obesity Care Continuum (OCC) partners agree with the premise behind a recent European Court of Justice ruling supporting disability protections for obesity under certain circumstances and call for these protections to be enacted in the United States.
The American Association of Neuromuscular & Electrodiagnostic Medicine is now accepting abstracts for its 2020 annual meeting in Orlando, Florida.
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society (AHS) in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT. The presentation will show that the Company's investigational LEVADEX™ orally inhaled migraine therapy was effective irrespective of when it was administered during a migraine cycle.
A new guideline published in this week's BMJ will help to tackle one of the leading causes of illness and death during pregnancy.
› Verified 3 days ago
Richard Raynor, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2105 E Watermill Rd, Marshall, MO 65340 Phone: 660-886-6730 | |
Mica K Newman-koehn, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2303 S Highway 65, Marshall, MO 65340 Phone: 660-886-3364 Fax: 660-886-6044 | |
Dr. Kurt Schroer, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 S Highway 65 Bldg A, Marshall, MO 65340 Phone: 660-886-7800 Fax: 660-831-3328 | |
Dr. Justin Robert Cramer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1825 Atchison Ave, Marshall, MO 65340 Phone: 660-886-8584 Fax: 888-979-8868 | |
Dr. Jared Karl Romney, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 S Highway 65, Marshall, MO 65340 Phone: 660-886-7431 Fax: 660-831-3325 | |
Dr. Sonal Patel Brizendine, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2305 South 65 Highway, Building A, Marshall, MO 65340 Phone: 660-886-7800 Fax: 660-831-3328 | |
Dr. Jamie G Ulbrich, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2303 S Highway 65, Marshall, MO 65340 Phone: 660-886-3364 Fax: 660-886-6044 |